
AVORO CAPITAL ADVISORS LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | TSHA | 21.70M | $97.00M |
![]() | OCUL | 12.31M | $104.31M |
CENTESSA PHARMACEUTICALS PLC | CNTA | 11.43M | $454.02M |
![]() | ARWR | 10.70M | $670.89M |
![]() | KYMR | 7.47M | $622.57M |
![]() | GPCR | 6.56M | $315.98M |
![]() | QURE | 5.96M | $97.44M |
![]() | VERA | 5.89M | $236.91M |
![]() | XENE | 5.78M | $335.98M |
![]() | ASND | 5.06M | $1.16B |
![]() | DFTX | 5.00M | $94.50M |
![]() | DMRA | 3.78M | $97.98M |
![]() | CELC | 3.38M | $385.22M |
![]() | CYTK | 3.33M | $219.70M |
![]() | KRYS | 2.89M | $746.26M |
![]() | UTHR | 2.63M | $1.56B |
![]() | RVMD | 2.34M | $228.00M |
![]() | MNKD | 2.20M | $5.39M |
![]() | LXEO | 1.88M | $10.76M |
![]() | MDGL | 1.82M | $951.76M |

Taysha Gene Therapies, Inc.
TSHA
Shares Held
21.70M
Value
$97.00M

Ocular Therapeutix, Inc.
OCUL
Shares Held
12.31M
Value
$104.31M
CENTESSA PHARMACEUTICALS PLC
CNTA
Shares Held
11.43M
Value
$454.02M

Arrowhead Pharmaceuticals, Inc.
ARWR
Shares Held
10.70M
Value
$670.89M

Kymera Therapeutics, Inc.
KYMR
Shares Held
7.47M
Value
$622.57M

Structure Therapeutics Inc.
GPCR
Shares Held
6.56M
Value
$315.98M

uniQure N.V.
QURE
Shares Held
5.96M
Value
$97.44M

Vera Therapeutics, Inc.
VERA
Shares Held
5.89M
Value
$236.91M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
5.78M
Value
$335.98M

Ascendis Pharma A/S
ASND
Shares Held
5.06M
Value
$1.16B

Definium Therapeutics, Inc.
DFTX
Shares Held
5.00M
Value
$94.50M

Damora Therapeutics, Inc.
DMRA
Shares Held
3.78M
Value
$97.98M

Celcuity Inc.
CELC
Shares Held
3.38M
Value
$385.22M

Cytokinetics, Incorporated
CYTK
Shares Held
3.33M
Value
$219.70M

Krystal Biotech, Inc.
KRYS
Shares Held
2.89M
Value
$746.26M

United Therapeutics Corporation
UTHR
Shares Held
2.63M
Value
$1.56B

Revolution Medicines, Inc.
RVMD
Shares Held
2.34M
Value
$228.00M

MannKind Corporation
MNKD
Shares Held
2.20M
Value
$5.39M

Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
1.88M
Value
$10.76M

Madrigal Pharmaceuticals, Inc.
MDGL
Shares Held
1.82M
Value
$951.76M
